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ABSTRACT
Objective To compare the effectiveness of ultrasound
guided corticosteroid injection in the subacromial bursa
with systemic corticosteroid injection in patients with
rotator cuff disease.
Design Double blind randomised clinical trial.
Setting Outpatient clinic of a physical medicine and
rehabilitation department in Oslo, Norway.
Patients 106 patients with rotator cuff disease lasting at
least three months.
Interventions Ultrasound guided corticosteroid and
lidocaineinjectioninthesubacromialbursaandlidocaine
injectionintheglutealregion(localgroup);corticosteroid
and lidocaine injection in the gluteal region and
ultrasound guided lidocaine injection in the subacromial
bursa (systemic group).
MainoutcomemeasuresDifferenceinimprovementinthe
overall shoulder pain and disability index score after six
weeks.
Results Six weeks after the intervention, the mean
difference in improvement in overall shoulder pain and
disability index score between the local group and the
systemic group was −5.2 (95% confidence interval −13.9
to3.5);itwas−4.1(−12.3to4.1,P=0.32)afteradjustment
for baseline score. A small but statistically significant
difference in improvement between groups occurred in
favour of the local group for two secondary outcome
measures:theWesternOntariorotatorcuffindex(8.1,0.7
to 15.6) and change in main complaint (2.0, 0 to 4).
Conclusions No important differences in short term
outcomes were found between local ultrasound guided
corticosteroid injection and systemic corticosteroid
injection in rotator cuff disease.
Trial registration Clinical trials NCT00640575.
INTRODUCTION
Shoulder pain is a common medical problem; impin-
gement syndrome or rotator cuff disease is the most
frequent diagnosis.
12 The exact source and mechan-
isms of pain in rotator cuff disease are not known.
3
Histopathology studies reveal mainly degenerative
changes of the rotator cuff tendons.
4 Inflammatory
mediators, free nerve endings, and nociceptive agents
have been found in the subacromial bursa,
56but other
factors may contribute to pain and dysfunction.
Non-operative treatment for rotator cuff disease
primarily consists of active physiotherapy, which may
besupplementedwithnon-steroidalanti-inflammatory
drugs, steroid injections, and electrotherapy.
3 Active
physiotherapy has been reported to be superior to
placebo and equivalent to surgery at long term follow-
up.
78 Despite extensive research, evidence for the
effectiveness of steroid injections for rotator cuff
disease is unconvincing. Conclusions of systematic
reviews and meta-analyses are inconsistent and ham-
pered by small sample sizes, variable methodological
quality, and heterogeneity of the included studies.
9-11
Corticosteroids are potent anti-inflammatory and
pain modulating drugs with both systemic and local
effects. The precise mechanism of local corticosteroid
injections is not well understood. Possible therapeutic
mechanisms include anti-inflammatory effects, relaxa-
tion of reflex muscle spasm, influence of local tissue
metabolism,painrelief,mechanicalimprovement,and
placebo effect.
12
Thirty per cent to 80% of subacromial injections are
reported to reach the subacromial bursa or the
subacromial space when a blind injection technique is
used.
13 High frequency ultrasonography is a safe,
accurate, readily available technique for guiding
musculoskeletalaspirationandinfiltrationthatensures
correct placement of the needle and delivery of the
drug. Some studies have reported better short term
improvement in patients when the injection has been
placed accurately into an anatomical site or in the
subacromial bursa.
1415 Valtonen reported that gluteal
andsubacromialcorticosteroidinjectionssignificantly,
and equally, improved supraspinatus tendonitis com-
pared with placebo.
16 Recently, two small randomised
trials reported that ultrasonographically guided injec-
tions were significantly more effective than blind
injections for short term pain relief and improved
function.
1718 The participants were not blinded for
treatment group in these two studies, which raises the
possibility of a bias favouring ultrasound guided
injections.
To investigate the importance of placement of
corticosteroid injections in patients with rotator cuff
disease,wedidarandomisedcontrolledstudycompar-
ing the effectiveness of a systemic corticosteroid
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guided injection in the subacromial bursa in patients
with rotator cuff disease. We used a double blind
design.
METHODS
This study was a prospective, double blind, rando-
mised controlled trial. We recruited patients between
April 2005 and October 2006. We invited general
practitioners in Oslo, serving a population of half a
million,toreferpatientswithrotatorcuffdiseasetothe
outpatient clinic of the Physical Medicine and Reha-
bilitationDepartmentatUllevålUniversityHospitalin
Norway. We included patients who were at least
18yearsoldandhadallofthefollowing:shoulderpain
for more than three months; pain on abduction; less
than a 50% reduced glenohumeral range of motion in
no more than one direction of external rotation,
internal rotation, or abduction; pain on two of three
isometric tests for abduction, external rotation, and
internal rotation; and a positive Hawkins-Kennedy
impingement sign.
19
We excluded patients who had symptomatic acro-
mioclavicular arthritis, clinical and radiological find-
ings indicatingglenohumeral joint pathology, referred
pain from the neck or internal organs, generalised
muscular pain syndrome with bilateral muscular pain
in the neck and shoulders, a history of inflammatory
arthritis,diabetesmellitus type1, previousfracturesor
surgery to the shoulder, or contraindications to local
steroid injections or if they had received any corticos-
teroids the last month before inclusion. We also
excluded patients with a shoulder pain and disability
index score below 30 points, representing minor
complaints that did not indicate corticosteroid injec-
tions.
The same medical doctor (OME) examined all
patients referred to the clinic for eligibility. They
were thoroughly informed about the study and signed
aninformedconsentiftheywerewillingtoparticipate.
Study protocol
Wescheduledpatientswhowereeligibleandwillingto
participateinthestudyforanappointmentattheclinic
for baseline registrations and treatment according to
the protocol. We recorded magnetic resonance ima-
ging results. Patients not able or unwilling to have
magneticresonanceimaginghaddiagnosticultrasono-
graphy. Patients had an equal probability of assign-
ment to the two treatment groups. We used the
computer program Clinstat to generate a predeter-
mined randomisation sequence with a randomised
variableblocksizeofthree,four,andfive.Amemberof
the study group who was not participating in patients’
eligibility, allocation to treatment, or outcome assess-
ment developed the randomisation sequence. The
consultantphysicianresponsiblefortheinjectionsheld
theonlycopyoftherandomisationsequence.Afterthe
baselineregistrations,wegaveeachparticipantastudy
number. To ensure concealed allocation, each patient
wasreferredtotheconsultantphysicianresponsiblefor
injections, who then allocated the patient to one of the
treatment groups according to the randomisation
sequence. Patients and the outcome assessor were
blinded for treatment assignment. The consultant
physician preparing and administering the injections
was not blinded.
Treatment
We allocated patients randomly to either local or
systemic steroid injection. Both groups received
injections of local anaesthetic in the shoulder and the
gluteal region. We provided local anaesthetic to
improve blinding of participants by inducing a
temporary pain relief (impingement test) and mask
possible post-injection pain. The “local” group
received a sonographically guided injection of 2 ml
(10 mg/ml) triamcinolone (Kenacort-T, Bristol-Myers
Squibb) and 5 ml (10 mg/ml) lidocaine hydrochloride
(Xylocaine,AstraZeneca)tothesubacromialbursaand
anintramuscularinjectionof4ml(10mg/ml)lidocaine
hydrochloride to the upper gluteal region. The
“systemic” group received a sonographically guided
injectionof5ml(10mg/ml)lidocainehydrochlorideto
the subacromial bursa and an intramuscular injection
of2ml(10mg/ml)triamcinoloneand2ml(10mg/ml)
lidocaine hydrochloride to the upper gluteal region.
Theinjectionprocedurewasstandardised.Thesame
independent consultant physician responsible for the
injections prepared syringes immediately before use.
She gave the sonographically guided injection first,
usingcommercialultrasoundequipment(Medison128
BWprime,MedisonCo,Seoul,Korea)witha5-9MHz
linear transducer for guidance. Patients sat facing the
ultrasound screen with the affected arm rotated inter-
nally behind the back, elbow bent, and the back of the
hand resting against the lower back. The physician
sterilised patients’ skin and the ultrasound transducer
with alcohol and applied sterile gel to the transducer.
Sheusedtheultrasoundprobetovisualisetheinsertion
ofthesupraspinatustendonandthesubacromialbursa
onthelongitudinalaxis,takingcarethatthecontentsof
the syringes were never shown to the participants. She
used the anterior approach with a 0.8×50 mm intra-
muscularneedleforthesubacromialinjections,perfor-
atingtheskinandtrackingtheneedleinrealtimeuntilit
reached the subacromial bursa. She emptied the
content of the syringe into the subacromial bursa,
takingcaretoavoiddirectinjectionintotherotatorcuff
tendons. The physician then gave patients the intra-
muscular injection in the upper gluteal region. We
allowed patients to use analgesics in the trial period,
and to continue any physiotherapy programme that
theywereattendingatbaseline.Wedidnotallowother
additional treatment in the research period.
Outcome measures
Blind follow-up measures were carried out at two and
six weeks after treatment. Baseline demographics and
clinical characteristics included sex, age, duration of
symptoms, sickness leave, worker’s compensation
claims, dominant side affected, previous episodes of
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symptom checklist to measure emotional distress.
20
We asked patients to report additional treatment at
follow-ups. The main outcome measure was the
shoulder pain and disability index.
21 This is a self
administered, validated, shoulder specific question-
naire consisting of five pain and eight disability items.
Patients recorded responses on each item on visual
analogue scales on the basis of the previous week’s
symptoms. We calculated the score by summing and
then averaging the two subscales to give a score out of
100. Secondary outcome measures were the Western
Ontario rotator cuff index
22; active range of abduction
and flexion; the participant’s assessment of change in
themaincomplaintcomparedwithbaseline,measured
onan18pointordinalscale;andtwoseparatequestions
aboutpainatrestandpainduringactivitymeasuredon
a nine point ordinal scale.
23 Patients completed all
questionnaires before the consultation and were
assessed by the same physician (OME) blinded for
treatment group. He measured active abduction and
flexion with an electronic digital inclinometer (EDI
320, Cybex Inc, Ronkonkoma, NY) according to a
standardised protocol.
24
Statistical analysis
Afterapilotstudy,weestimatedthestandarddeviation
of change in shoulder pain and disability index to be
approximately 20 points. The minimal clinically
important difference has been variously reported to
be10pointsand13.2points.
2526Wedesignedthisstudy
to detect a clinically relevant difference of 10 points
with 95% probability and 80% power. We needed a
samplesizeof63patientspergroupforatwosidedttest
and48patientspergroupforthemoreefficientanalysis
of covariance.
27 To account for a 10% rate of loss at
follow-up and still meet these requirements, we
included 106 patients in the study. We did not plan or
do any interim analyses.
We analysed data according to the principle of
intention to treat. All hypothesis tests were two tailed
with a significance level of 5%. We calculated point
estimates with associated 95% confidence intervals for
mean differences in improvement between groups in
shoulder pain and disability index score and Western
Ontario rotator cuff index score. For analysis of
participants’ change in main complaint, pain at rest,
andpainduringactivity,wecalculatednon-parametric
estimateswithmedian,interquartilerange,andmedian
difference in improvement between groups with 95%
confidence intervals. As recommended, we planned
a n du s e da na n a l y s i so fc o v a r i a n c em o d e lw i t h
adjustment for baseline differences.
28 We used the
Mann-Whitney U test for hypothesis testing of group
differences in main complaint. We used Minitab
15.1.1.0 and Confidence Interval Analysis 2.1.2 to
calculate non-parametric statistics and SPSS 16.0 for
Mac for all other statistical analyses. We reported the
study according to the CONSORT rules.
RESULTS
Of the 312 patients evaluated for inclusion, we
randomised 106. The figure shows the reasons for
exclusion and the follow-up of patients through the
trial. One patient in each treatment group did not
attend the two week follow-up. Two patients in the
systemic group were not available at the six week
follow-up (one had a medical condition and the other
could not be reached). For these patients, we carried
forwardthelastreportedvaluesintheintentiontotreat
analysis. One patient in the systemic group withdrew
from the study after the two week follow-up and
received an additional corticosteroid injection in the
shoulder. We included these results in the intention to
treat analyses. The outcome for this patient was poor.
Table 1 shows the baseline characteristics of the
studysample.Atbaseline,thegroupsweresimilarwith
respect to sex, age, duration of symptoms, sickness
leave, worker’s compensation claims, dominant side
affected, concomitant neck pain, previous episodes of
shoulder pain, emotional distress, and use of analge-
sics. Eight patients were not able or were unwilling to
have magnetic resonance imaging and had diagnostic
ultrasonography.Five patientsineachgrouphadafull
thickness rotator cuff tear. Eight patients in the local
group and five patients in the systemic group attended
physiotherapy between baseline and the six week
follow-up.Thegroupsdidnotdifferindruguse,andno
patient reported attending for other treatments in the
trialperiod.Allprocedureswereimplementedwithout
difficulties. Seven (24%) of 29 patients in the local
groupand19(50%)of38patientsinthesystemicgroup
Excluded (n=206):
  Not meeting inclusion criteria (n=173)
    Other diagnosis (n=140): muscular pain (35), adhesive capsulitis (31), GH arthritis (8),
      instability/labrum/SLAP injury (19), other shoulder diagnosis (29), cervical syndrome
      (7), other diagnosis (11).
    Previous treatment (n=11)
    SPADI<30 (n=8)
    Duration of illness less than 3 months (n=3)
    Not able to fill in questionnaires (n=11)
  Refused to participate (n=33)
Assessed for eligibility (n=312)
Enrolment
Randomly allocated to treatment (n=106)
Allocated to group I and
received local injection (n=53)
Allocated to group II and
received systemic injection (n=53)
Attended follow-up at 2 weeks (n=52)
  Unavailable at follow-up (n=1)
Attended follow-up at 2 weeks (n=52)
  Unavailable at follow-up (n=1)
  One patient withdrew from the study after the
    2 week follow-up and received a
    corticosteroid injection in the shoulder
Attended follow-up at 6 weeks (n=53) Attended follow-up at 6 weeks (n=51)
  Unavailable at 6 week follow-up (n=1)
  Medical problem (n=1)
Flow chart of study. GH=glenohumeral; SLAP=superior labrum, anterior to posterior;
SPADI=shoulder pain and disability index
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assigned to (P=0.055). Thirty nine (37%) patients did
not answer the question about which treatment they
believed they had received.
Table 2 shows the improvement in shoulder pain
anddisabilityindexscoresforbothgroupsoverthesix
weekperiod.Themeandifferencefrombaselinetothe
sixweekfollow-upwas24.4(SD22.5,P<0.001)forthe
local group and 19.2 (SD 22.7, P<0.001) for the
systemic group. The results at the six week follow-up
were slightly in favour of the group receiving local
injections for all outcome measures. The difference in
effectiveness of treatment between the two groups in
the primary outcome measure was small and not
statistically significant at any time point, even after
adjustmentforbaselinedifferenceinshoulderpainand
disability index score (mean difference −4.1, 95%
confidence interval −12.3 to 4.1, P=0.32) (table 2).
After adjusting for baseline difference in Western
Ontariorotatorcuffindexscore,wefoundasignificant
difference between groups of 8.1 (95% confidence
interval 0.7 to 15.6, P=0.032) points at the six week
follow-up in favour of patients receiving local injec-
tions. The participants’ reported change in main
complaint from baseline to six week follow-up was 6
(range 3-7) versus 2 (range 0-7), and the median
difference between the groups was 2 (95% confidence
interval 0 to 4, P=0.009) in favour of the local group.
We found no significant difference between groups in
rangeofabduction,rangeofflexion,orthetwoseparate
pain questions at two week and six week follow-ups
(table 2).
Onlyfivepatientsreceivinglocalinjectionsandthree
patientsreceivingsystemicinjectionshadanormaland
pain-freerangeofabductionandnegativeclinicaltests.
Nine patients from both groups reported mild adverse
effects such as facial redness, dizziness, and feeling of
warmth. One patient in the local group and four
patients in the systemic group reported post-injection
pain in the shoulder. No serious side effects were
reported.
DISCUSSION
Ourmainobjectivewastocomparetheeffectivenessof
ultrasound guided subacromial injection and systemic
gluteal injection of corticosteroids in patients with
rotatorcuffdisease.Wedidnotfindsignificantbetween
group differences in the primary outcome measure.
Although4.1 points is the bestestimate of the between
groupdifferencesinimprovementoftheshoulderpain
and disability index score in this study, the 95%
confidence interval includes the 10 point threshold we
usedasaminimalclinicallyimportantdifferencewhen
designing the study. We therefore cannot exclude the
possibility of a between group difference. A recent
study estimated the minimal clinically important
difference in shoulder pain and disability index score
tobe13.2points;accordingly,ourobservedresultsare
not clinically important.
26
Interpretation of results
We reported statistically significant, but clinically
small, group differences for two secondary outcome
measures. The observed inconsistency between out-
come measures may be due to the effects of multiple
testing, which increase the probability of positive
results. With Bonferroni corrections, no results
remained statistically significant. Conclusions of effec-
tiveness of an intervention may be influenced by the
choice of scoring system for rating patients.
2930 We
cannotruleoutthepossibilitythattheWesternOntario
rotatorcuffindexisamoresensitiveoutcomemeasure
thantheshoulderpainanddisabilityindex.Clinimetric
studiesinvestigatingtheresponsivenessoftheshoulder
pain and disability index and the Western Ontario
rotator cuff index with other shoulder questionnaires
indicate that both outcome measures are
responsive.
3132 The two scores may measure different
constructs,however,astheshoulderpainanddisability
index is a pain and disability score and the Western
Ontario rotator cuff index is a health related quality of
lifescore.Consensusonacoresetofoutcomemeasures
in shoulder interventions is warranted.
The most likely interpretation of our results is that
localultrasoundguidedcorticosteroidinjectionsdonot
improve patients’ outcomes compared with systemic
corticosteroid injection in rotator cuff disease.
Comparison with existing literature
Previous randomised trials and systematic reviews
havereportedcontradictoryresultsontheeffectiveness
of corticosteroid injections for rotator cuff disease.
911
Alvarez et al compared blind injection of
Table 1 |Baseline characteristics according to group. Values are numbers (percentages) unless
stated otherwise
Characteristic Local group (n=53) Systemic group (n=53)
Sex (male/female) 21/32 20/33
Mean (SD) age (years) 51 (11) 50 (12)
Symptom duration:
<6 months 15 (28) 15 (28)
6 months to 1 year 17 (32) 15 (28)
1 - 2y e a r s 7( 1 3 ) 1 1( 2 1 )
>2 years 14 (26) 12 (23)
Work:
On sick leave 17 (32) 14 (26)
Median (interquartile range) duration of sick leave
(months)
8 (1-14) 4 (3-17)
Worker’s compensation claim 5 (9) 3 (6)
Bilateral pain 8 (15) 9 (17)
Dominant side affected 34 (64) 35 (66)
Full thickness rotator cuff rupture 5 (9) 5 (9)
Hopkins symptom checklist—mean (SD) sum score* 1.53 (0.42) 1.53 (0.38)
Previous treatment:
Physiotherapy 29 (55) 23 (43)
Corticosteroid injection 22 (42) 20 (38)
Current additional treatment:
Physiotherapy 9 (17) 6 (11)
Analgesics 19 (36) 21 (40)
*Local group n=48; systemic group n=50.
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rotator cuff disease. They found a moderate improve-
ment in symptoms in both groups but found no
difference in improvement between groups.
33 Con-
siderableplaceboeffectshavebeenseenwithinjection
treatment, acupuncture, and extracorporeal shock
wavetherapyforshoulderdisease.
34-36Thus,ourresults
couldbeattributedtothesystemiceffectofcorticoster-
oids,injectionsoflidocaineintothesubacromialbursa,
and placebo effects.
Naredo et al and Chen et al have reported better
outcomesforpain,disability,andrangeofmotionafter
ultrasound guided injections than blind subacromial
injections.
1718 Thus, we cannot rule out the possibility
that the use of ultrasound for better placement of
lidocaine injections contributed to the results of our
study. We used 20 mg of triamcinolone to parallel the
doseusedinthestudybyNaredoetal.Severalprevious
studies have used higher doses of corticosteroid
injections for rotator cuff disease. Limited evidence
exists for better efficacy with higher corticosteroid
dosage,
10 but 20 mg of triamcinolone is generally
regardedasalowdoseforsystemictreatment.Ahigher
dosage would be likely to reduce the difference
between groups and increase adverse effects.
Possible confounders and weaknesses
The effectiveness of corticosteroid injections might be
influenced by the duration of rotator cuff disease. The
favourable result of ultrasound guided corticosteroid
injections in the study by Naredo et al occurred in a
group of patients with a first flare of shoulder pain.
18
Longstanding symptoms are a negative prognostic
factor for clinical outcome.
3738 A large portion of
patients in our study had had symptoms for more than
six months, and many patients had recurring episodes
of shoulder pain. No differences existed in duration of
disease between groups in our study.
We based inclusion of patients on strict clinical
criteria.
23ThisstrategyisinaccordancewithParketal,
whofoundthattheuseofacombinationofclinicaltests
increased the accuracy of clinical diagnosis.
39 Our
inclusion criteria are quite similar, but not identical, to
the criteria used in the study by Park et al. By
combining the Hawkins-Kennedy impingement sign,
the painful arc sign, and the infraspinatus muscle
strength test, they achieved a post-test probability of
95% for any degree of impingement syndrome. In our
study, the clinical classification of soft tissue shoulder
disordersanduseofstrictinclusioncriterialoweredthe
Table 2 |Outcome measures
Measure Local group (n=53)
Systemic group
(n=53)
Differenceinimprovement
(95% CI)
Adjusted difference
(95% CI) P value
Shoulder pain and disability index— —mean (SD)
Baseline 53 (18) 51 (17) –– –
2 weeks 32 (25) 28 (23) 0.8 (−7.9 to 9.4) ––
6 weeks 29 (21) 32 (23) −5.2 (−13.9 to 3.5) −4.1 (−12.3 to 4.1) 0.32
Western Ontario rotator cuff index*— —mean (SD)
Baseline 45 (17) 47 (16) –– –
2 weeks 64 (23) 63 (22) 3.0 (−4.6 to 10.6) ––
6 weeks 67 (21) 60 (22) 9.0 (1.2 to 16.8) 8.1 (0.7 to 15.6) 0.032
Abduction† †— —median (interquartile range)
Baseline 131 (98-144) 126 (88-144) –– –
2 weeks 140 (130-148) 133 (108-146) −2( −11 to 7) ––
6 weeks 141 (122-150) 121 (99-144) −4( −12 to 4) −6( −15.9 to 3.8) 0.23
Flexion† †— —median (interquartile range)
Baseline 151 (132-160) 150 (129-158) –– –
2 weeks 158 (148-164) 150 (134-161) −4( −10 to 1) ––
6 weeks 156 (148-166) 152 (132-160) −2( −8t o5 ) −4.4 (−14.7 to 5.9) 0.40
Pain at rest† †— —median
Baseline 6.0 7.0 –– –
2 weeks 4.0 4.0 0 (−1.0 to 1.0) ––
6 weeks 3.0 5.0 1.0 (0 to 2.0) −0.6 (−1.5 to 0.2) 0.13
Pain in activity† †— —median
Baseline 6.0 7.0 –– –
2 weeks 3.0 2.0 0 (−1.0 to 1.0) ––
6 weeks 2.0 3.0 1.0 (0 to 2.0) −0.5 (−1.1 to 0.2) 0.19
Change in main complaint† †— —median
2 weeks 5.0 4.0 1.0 (0 to 2.0) ––
6 weeks 6.0 2.0 2.0 (0 to 4.0) –‡ 0.009§
*Local group n=52; systemic group n=52.
†Non-parametric statistics.
‡No adjustment possible for baseline score.
§Mann-Whitney test of hypothesis of difference between medians v no difference.
RESEARCH
BMJ | ONLINE FIRST | bmj.com page 5 of 7external validity with respect to the 312 patients
considered for inclusion.
Twentypatientsinthelocalgroupand18patientsin
the systemic group had had previous shoulder injec-
tions. Eight patients in the local group and five in the
systemic group had concurrent physiotherapy. Both
previous and concurrent treatment might have influ-
enced individual treatment response, but these possi-
bleconfoundersexistedinthesamenumberofpatients
in eachinterventiongroup. Wedidnotregistertypeof
physiotherapy or use a structured reportingsystem for
additionaldrugusesuchasthedefineddailydoseorthe
anatomical therapeutic chemical classification system
that could have revealed a bias in compliance caused
by these potential confounders.
Aweaknessinthe designof thestudywasthe lackof
blindingofthephysicianwhogavetheinjections.Even
though we standardised the procedure and took care
not to reveal group assignment, a bias may have been
introduced. If present, we believe the bias was most
likely to be in favour of the local group on the basis of
the good results of recent studies using ultrasound
guided corticosteroid injections and the fact that the
physician responsible for giving injections had specia-
lised in diagnostic ultrasonography and ultrasound
guided injections.
We set the period of time between treatment and
follow-up testing to optimise the anticipated pharma-
cological effect of the injected steroid. Evidence of the
effectiveness of long term treatment is scant.
40 Recent
studies have reported better short term and inferior
longtermresultsfromcorticosteroidinterventionthan
fromphysiotherapyandnointervention(controls).
4142
The modest improvements in self reported com-
plaints and range of motion after steroidinjection seen
in this and previous studies suggest that steroid
injection is not a sufficient treatment strategy for
patients with rotator cuff disease. Better outcome in
termsofrangeofmotionisreportedafterattendanceat
an active physiotherapy programme.
7843
Conclusion
The results of this study do not indicate that local
corticosteroid injection is more effective than systemic
corticosteroid injectionforshort termimprovementin
rotator cuff disease. Ultrasound guided injection of
lidocaine into the subacromial bursa might have
contributed to the observed improvement in both
groups.
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